From the last PR - it looks like FDA approval.
Post# of 36501
Contingent on FDA approval and the receipt of financing the final vaccine manufacturing process is commercial ready using a lyophilization method that produces a stable, powdered Ii-Key-SARS-CoV-2 vaccine that can potentially be shipped and stored at room temperature, providing a substantial commercial advantage.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)